Log in

GLUC Glucose Health, Inc. OTC · United States

Glucose Health (GLUC) news

Glucose Health, Inc. is a public biotech or pharmaceutical company listed on OTC under the ticker GLUC, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Glucose Health news

We have not published a story on Glucose Health yet. When there is news, it will appear here.

Glucose Health annual financials

LineFY2016FY2015
Research and development$48
Net income (loss)-$410,443-$266,064
Cash from operations-$39,263-$115,776
Cash and equivalents$20,542$2,055

Latest balance sheet, Sep 30, 2017 (10-Q): cash and equivalents $16,636.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

Questions about Glucose Health

What is the ticker symbol of Glucose Health?

Glucose Health, Inc. trades under the ticker GLUC on OTC.

Where is Glucose Health listed?

Glucose Health, Inc. is listed on OTC.

Which country or territory is Glucose Health listed under?

Our directory records Glucose Health, Inc. under United States.

Does aibio.space cover Glucose Health?

aibio.space lists Glucose Health, Inc. among 2,820 public biotech companies and publishes its news here as stories appear.

Is Glucose Health profitable?

Glucose Health, Inc. reported a net loss of $410,443 for the fiscal year ended Dec 31, 2016, and used $39,263 of cash in operations, per its annual report to the SEC.

How much cash does Glucose Health have?

$16,636 in cash at Sep 30, 2017, per its 10-Q.

Investor discussion: Glucose Health

Members talk about Glucose Health (GLUC). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open OTC:GLUC on TradingView.

Listing details

Glucose Health, Inc. is a public biotech or pharmaceutical company listed on OTC under the ticker GLUC, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Glucose Health, Inc.
Ticker
GLUC
Listing
OTC
Country or territory
United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.